Filings For: Drugs Made In America Acquisition Corp.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Drugs Made In America Acquisition Corp. (DMAAU) 8/15/2026 4:03:21 AM Small View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Assets $146,903,435 EPS $0.06
Drugs Made In America Acquisition Corp. (DMAAU) 5/14/2026 5:14:30 PM Small View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Assets $242,035,303 EPS $0.06
Drugs Made In America Acquisition Corp. (DMAAU) 4/16/2026 4:07:10 PM   View Proxy SEC Y 2025
Drugs Made In America Acquisition Corp. (DMAAU) 4/15/2026 5:25:42 PM Small View Financials 10-K SEC Y 2025 ending: 12/31/2025 Assets $239,918,847 EPS $0.38
Drugs Made In America Acquisition Corp. (DMAAU) 4/14/2026 4:09:43 PM   View Proxy SEC Y 2025
Drugs Made In America Acquisition Corp. (DMAAU) 11/18/2025 4:16:56 PM Micro View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025
Drugs Made In America Acquisition Corp. (DMAAU) 8/14/2025 4:37:09 PM Micro View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025
Drugs Made In America Acquisition Corp. (DMAAU) 5/20/2025 5:36:04 PM Micro View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025
Drugs Made In America Acquisition Corp. (DMAAU) 3/31/2025 4:16:50 PM Micro View Financials 10-K SEC Y 2024 ending: 12/31/2024